Equities

Infant Bacterial Therapeutics AB

Infant Bacterial Therapeutics AB

Actions
Health CarePharmaceuticals & Biotechnology
  • Price (SEK)218.00
  • Today's Change0.00 / 0.00%
  • Shares traded10.15k
  • 1 Year change16.27%
  • Beta--
Data delayed at least 15 minutes, as of May 23 2019 17:00 BST.
More ▼

    Key statistics

    Infant Bacterial Therapeutics AB (IBT B:STO) set a new 52-week high during today's trading session when it reached 219.00. Over this period, the share price is up 13.25%.
    52-week range
    Today
    115.00Nov 23 2018219.00May 23 2019
    Markit short selling activity
    Low
    Med
    High
    Open218.50
    High219.00
    Low215.00
    Bid218.00
    Offer218.00
    Previous close218.00
    Average volume13.31k
    Shares outstanding10.85m
    Free float9.50m
    P/E (TTM)--
    Market cap2.36bn SEK
    EPS (TTM)-2.86
    SEK
    Data delayed at least 15 minutes, as of May 23 2019 17:00 BST.
    More ▼
    The Financial and Risk business of Thomson Reuters is now Refinitiv
    All markets data located on FT.com is subject to the FT Terms & Conditions
    All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
    Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
    Markit Short Selling Activity © Markit. All rights reserved.
    Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.